22 healthy participants will randomly be allocated to receive PACAP38 infusion followed by glibenclamide or placebo on two different days.~The aim of the study is to investigate the vascular effect of PACAP38 after glibenclamide administration.~Repeated measurements covering the arteria radialis (RA), superficial temporal artery (STA) and middle cerebral artery (MCA) before and after PACAP38 infusion and glibenclamide/placebo administration
To investigate the hemodynamic effects of PACAP38 after glibenclamide administration.